Medicalgorithmics enters the key Middle Eastern market – Saudi Arabia – with its groundbreaking VCAST solution
WSE-listed Medicalgorithmics has signed an agreement with Umbrella Biomed, one of the leading healthcare companies in Saudi Arabia and the broader MENA region. Under this agreement, the Polish medtech’s AI-powered cardiac imaging technology – VCAST, positioned as a competitive alternative to U.S. firms such as HeartFlow and Clearly, will – upon completion of the integration process and receipt of relevant regulatory approvals – be made available to Umbrella Biomed’s extensive customer base in Saudi Arabia. The signed agreement, which includes contractual minimums, marks the third major large-scale distribution contract for VCAST, a software solution already certified for commercial use in the European Union.